INTRODUCTION: Topoisomerase 1 (TOP1) and 2A (TOP2A) are potential predictive biomarkers for irinotecan and anthracycline treatment, respectively, in colorectal cancer (CRC), and we have recently reported a high frequency of gene gain of the TOP1 and TOP2A genes in CRC. Furthermore, Mismatch Repair (MMR) subtypes of CRC have been associated with benefit from adjuvant chemotherapy of primary CRC. Given the involvement of the topoisomerase enzymes in DNA replication and repair, we raised the hypothesis that an association may exist between TOP gene copy numbers and MMR proficiency/deficiency in CRC. MATERIAL AND METHODS: Test cohort: FISH analysis with an in-house TOP1/CEN20 probe mix and a commercially available TOP2A/CEN17 (Dako, Glostrup, Denmark) probe mix was performed on archival formalin fixed paraffin embedded (FFPE) tissue samples from 18 patients with proficient MMR (pMMR) CRC and 18 patients with deficient MMR (dMMR) CRC. TOP1 and TOP2A gene copy numbers and their ratios per nucleus were correlated with MMR status using the Mann-Whitney test. Validation cohort: FFPE samples from 154 patients with primary stage III CRC (originally included in the RANX05 study) were classified according to MMR status by immunohistochemical analysis using validated antibodies for MLH1, MLH2, MSH6 and PMS2, and information on TOP1, CEN20, TOP2A and CEN17 status was previously published for this cohort. RESULTS: The observed TOP1 gene copy numbers in the 36 CRC test cohort were significantly greater (p < 0.01) in the pMMR subgroup (mean: 3.84, SD: 2.03) than in the dMMR subgroup (mean: 1.50, SD: 0.12). Similarly, the TOP2A copy numbers were significantly greater (p < 0.01) in the pMMR subgroup (mean: 1.99, SD: 0.52) than in the dMMR subgroup (mean: 1.52, SD: 0.10). These findings were confirmed in the validation cohort, where in the pMMR subgroup 51% had ≥2 extra TOP1 copies per cell, while all tumors classified as dMMR had diploid TOP1 status and mean TOP2A copy numbers were 2.30 (SD: 1.36) and 1.80 (SD: 0.31) (p = 0.01) in the pMMR subgroup vs. dMMR subgroup, respectively. DISCUSSION AND CONCLUSION: Our results show that TOP1 and TOP2A gene copy numbers are increased in the pMMR subgroup. We propose that this preference may reflect a selective pressure to gain and/or maintain the gained extra copies of topoisomerase genes whose products are required to cope with high replication stress present in the pMMR tumors, thereby providing a survival advantage selectively in pMMR tumors. Future studies should test this concept and explore potential differences between pMMR and dMMR tumors in response to Top1 and Top2 inhibitors.

Danish Cancer Research Center The Danish Cancer Society Strandboulevarden 49 DK 2100 Copenhagen Ø Denmark; Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Tr Svobody 8 771 26 Olomouc Czech Republic

Department of Pathology Herlev Hospital Herlev Ringvej 75 DK 2730 Herlev Denmark

Department of Surgical Gastroenterology Copenhagen University Hospital Hvidovre Kettegårds Allé 30 DK 2650 Hvidovre Denmark

Section of Molecular Disease Biology Department of Veterinary Disease Biology Faculty of Health and Medical Sciences Grønnegårdsvej 15 DK 1870 Frederiksberg C Denmark

Zobrazit více v PubMed

Bartek, J. , Mistrik, M. , Bartkova, J. , 2012. Thresholds of replication stress signaling in cancer development and treatment. Nat. Struct. Mol. Biol. 19, (1) 5–7. PubMed

Bartkova, J. , Horejsi, Z. , Koed, K. , Kramer, A. , Tort, F. , Zieger, K. , Guldberg, P. , Sehested, M. , Nesland, J.M. , Lukas, C. , Orntoft, T. , Lukas, J. , Bartek, J. , 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, (7035) 864–870. PubMed

Bermejo, R. , Lai, M.S. , Foiani, M. , 2012. Preventing replication stress to maintain genome stability: resolving conflicts between replication and transcription. Mol. Cell 45, (6) 710–718. PubMed

Boonsong, A. , Curran, S. , McKay, J.A. , Cassidy, J. , Murray, G.I. , McLeod, H.L. , 2002. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Hum. Pathol. 33, (11) 1114–1119. PubMed

Boonsong, A. , Marsh, S. , Rooney, P.H. , Stevenson, D.A. , Cassidy, J. , McLeod, H.L. , 2000. Characterization of the topoisomerase I locus in human colorectal cancer. Cancer Genet. Cytogenet. 121, (1) 56–60. PubMed

Braun, M.S. , Richman, S.D. , Quirke, P. , Daly, C. , Adlard, J.W. , Elliott, F. , Barrett, J.H. , Selby, P. , Meade, A.M. , Stephens, R.J. , Parmar, M.K. , Seymour, M.T. , 2008. Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. J. Clin. Oncol. 26, (16) 2690–2698. PubMed

Burrell, R.A. , McClelland, S.E. , Endesfelder, D. , Groth, P. , Weller, M.C. , Shaikh, N. , Domingo, E. , Kanu, N. , Dewhurst, S.M. , Gronroos, E. , Chew, S.K. , Rowan, A.J. , Schenk, A. , Sheffer, M. , Howell, M. , Kschischo, M. , Behrens, A. , Helleday, T. , Bartek, J. , Tomlinson, I.P. , Swanton, C. , 2013. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, (7438) 492–496. PubMed PMC

de Pender, A.M. , Alers, J.C. , Vissers, K.J. , de Both, N.J. , Dinjens, W.N. , van Dekken, H. , 2001. Evaluation of oncogene amplification in intact and truncated cell nuclei of gastro-esophageal cancer cell lines by DNA in situ hybridisation. Acta Histochem. 103, (2) 127–138. PubMed

Des Guetz, G. , Uzzan, B. , Nicolas, P. , Schischmanoff, O. , Perret, G.Y. , Morere, J.F. , 2009. Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis. Anticancer Res. 29, (5) 1615–1620. PubMed

Di Leo, A. , Desmedt, C. , Bartlett, J.M. , Piette, F. , Ejlertsen, B. , Pritchard, K.I. , Larsimont, D. , Poole, C. , Isola, J. , Earl, H. , Mouridsen, H. , O'Malley, F.P. , Cardoso, F. , Tanner, M. , Munro, A. , Twelves, C.J. , Sotiriou, C. , Shepherd, L. , Cameron, D. , Piccart, M.J. , Buyse, M. , 2011. HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data. Lancet Oncol. 12, (12) 1134–1142. PubMed

Du, Y. , Zhou, Q. , Yin, W. , Zhou, L. , Di, G. , Shen, Z. , Shao, Z. , Lu, J. , 2011. The role of topoisomerase II alpha in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures. Breast Cancer Res. Treat 129, (3) 839–848. PubMed

Geiersbach, K.B. , Samowitz, W.S. , 2011. Microsatellite instability and colorectal cancer. Arch. Pathol. Lab Med. 135, (10) 1269–1277. PubMed

Grady, W.M. , Carethers, J.M. , 2008. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135, (4) 1079–1099. PubMed PMC

Guastadisegni, C. , Colafranceschi, M. , Ottini, L. , Dogliotti, E. , 2010. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur. J. Cancer 46, (15) 2788–2798. PubMed

Halazonetis, T.D. , Gorgoulis, V.G. , Bartek, J. , 2008. An oncogene-induced DNA damage model for cancer development. Science 319, (5868) 1352–1355. PubMed

Koopman, M. , Knijn, N. , Richman, S. , Seymour, M. , Quirke, P. , van Tinteren, H. , 2009. The correlation between Topoisomerase-I (Topo1) expression and outcome of treatment with capecitabine and irinotecan in advanced colorectal cancer (ACC) patients (pts) treated in the CAIRO study of the Dutch Colorectal Cancer Group (DCCG). Eur. J. Cancer 321 Suppl. 7 PubMed

Kostopoulos, I. , Karavasilis, V. , Karina, M. , Bobos, M. , Xiros, N. , Pentheroudakis, G. , Kafiri, G. , Papakostas, P. , Vrettou, E. , Fountzilas, G. , 2009. Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy. BMC Cancer 9, 339 PubMed PMC

Lassmann, S. , Weis, R. , Makowiec, F. , Roth, J. , Danciu, M. , Hopt, U. , Werner, M. , 2007. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J. Mol. Med. (berl) 85, (3) 293–304. PubMed

Lengauer, C. , Kinzler, K.W. , Vogelstein, B. , 1997. Genetic instability in colorectal cancers. Nature 386, (6625) 623–627. PubMed

Michaelson, R. , Kemeny, N. , Young, C. , 1982. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma. Cancer Treat Rep. 66, (9) 1757–1758. PubMed

Moisan, F. , Longy, M. , Robert, J. , Le Morvan, V. , 2006. Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines. Br. J. Cancer 95, (7) 906–913. PubMed PMC

NCCN, 2014. Guidelines Version 3 Colon Cancer National Comprehensive Cancer Network; Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp

Nielsen, H.J. , McArdle, C. , Moesgaard, F. , The RANX05 Study Group1998. The effect of ranitidine on long-term survival in primary colorectal cancer. A 40 months interim analysis. GI Cancer 227–233.

Nielsen, K.V. , Ejlertsen, B. , Moller, S. , Jensen, M.B. , Balslev, E. , Muller, S. , Knoop, A. , Mouridsen, H.T. , 2012. Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status. Mol. Oncol. 6, (1) 88–97. PubMed PMC

Nygard, S.B. , Christensen, I.J. , Nielsen, S.L. , Nielsen, H.J. , Brunner, N. , Spindler, K.L. , 2014. Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer. Scand. J. Gastroenterol. 49, (1) 84–91. PubMed

Nygard, S.B. , Christensen, I.J. , Smith, D.H. , Nielsen, S.L. , Jensen, N.F. , Nielsen, H.J. , Vainer, B. , Brunner, N. , 2013. Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancer. Scand. J. Gastroenterol. 48, (12) 1436–1443. PubMed

Olsen, K.E. , Knudsen, H. , Rasmussen, B.B. , Balslev, E. , Knoop, A. , Ejlertsen, B. , Nielsen, K.V. , Schonau, A. , Overgaard, J. , 2004. Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes. Acta Oncol. 43, (1) 35–42. PubMed

Paradiso, A. , Xu, J. , Mangia, A. , Chiriatti, A. , Simone, G. , Zito, A. , Montemurro, S. , Giuliani, F. , Maiello, E. , Colucci, G. , 2004. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients. Int. J. Cancer 111, (2) 252–258. PubMed

Pena-Diaz, J. , Jiricny, J. , 2012. Mammalian mismatch repair: error-free or error-prone?. Trends Biochem. Sci. 37, (5) 206–214. PubMed

Pommier, Y. , Leo, E. , Zhang, H. , Marchand, C. , 2010. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol. 17, (5) 421–433. PubMed PMC

Poulsen, T.S. , 2007. Purification of BAC DNA. Bacterial Artificial Chromosomes Volume 1: Library Construction, Physical Mapping, and Sequencing. vol. 255, 91–100.

Poulsen, T.S. , Johnsen, H.E. , 2007. BAC End Sequencing. Bacterial Artificial Chromosomes Volume 1: Library Construction, Physical Mapping, and Sequencing. vol. 255, 157–162.

Romer, M.U. , Nygard, S.B. , Christensen, I.J. , Nielsen, S.L. , Nielsen, K.V. , Muller, S. , Smith, D.H. , Vainer, B. , Nielsen, H.J. , Brunner, N. , 2013. Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis. Mol. Oncol. 7, (1) 101–111. PubMed PMC

Smith, D.H. , Christensen, I.J. , Jensen, N.F. , Markussen, B. , Romer, M.U. , Nygard, S.B. , Muller, S. , Nielsen, H.J. , Brunner, N. , Nielsen, K.V. , 2013. Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. PLoS One 8, (4) e60613 PubMed PMC

Staley, B.E. , Samowitz, W.S. , Bronstein, I.B. , Holden, J.A. , 1999. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon. Mod. Pathol. 12, (4) 356–361. PubMed

Tsavaris, N. , Lazaris, A. , Kosmas, C. , Gouveris, P. , Kavantzas, N. , Kopterides, P. , Papathomas, T. , Agrogiannis, G. , Zorzos, H. , Kyriakou, V. , Patsouris, E. , 2009. Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy. Cancer Chemother. Pharmacol. 64, (2) 391–398. PubMed PMC

Wang, J.C. , 2002. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol 3, (6) 430–440. PubMed

Wils, J.A. , 1984. Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma. Invest New Drugs 2, (4) 397–399. PubMed

Wolman, S.R. , 1994. Fluorescence in situ hybridization: a new tool for the pathologist. Hum. Pathol. 25, (6) 586–590. PubMed

An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial